Earnings Feed
Start Free
Galera Therapeutics, Inc.·4

Mar 30, 4:42 PM ET

Sorensen Mel 4

4 · Galera Therapeutics, Inc. · Filed Mar 30, 2021

Insider Transaction Report

Form 4
Period: 2021-03-26
Galera Therapeutics, Inc.GRTX
Sorensen Mel
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-26$1.14/sh+46,940$53,512→ 232,044 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-03-26−46,940→ 0 total
    Exercise: $1.14Exp: 2024-09-16→ Common Stock (46,940 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-03-26−170,075→ 0 total
    Exercise: $1.07Exp: 2022-11-25→ Common Stock (170,075 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-26$1.07/sh+170,075$181,980→ 185,104 total
Footnotes (1)
  • [F1]The option has fully vested and is currently exercisable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION